The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer

FASEB Journal

Volumn 24, Issue 10, 2010, Pages 3882-3894

  Brizuela, Leyre ^a   Dayon, Audrey ^a   Doumerc, Nicolas ^a,b   Ader, Isabelle ^a   Golzio, Muriel ^a   Izard, Jean Claude ^c   Hara, Yukihiko ^d   Malavaud, Bernard ^a,b   Cuvillier, Olivier ^a,b  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b CHU RANGUEIL   (France)

^c Actichem SA   (France)

^d Mitsui Norin Co Ltd   (Japan)

Author keywords

EGCg; ERK1 2; Phospholipase D; Resveratrol

Indexed keywords

EPIGALLOCATECHIN GALLATE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE D; POLYPHENOL; RESVERATROL; SPHINGOSINE KINASE 1; UNCLASSIFIED DRUG; VINEATROL; PHOSPHOTRANSFERASE; SPHINGOSINE KINASE; TEA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TEA; TUMOR RESISTANCE; ANALYSIS; CHEMISTRY; HUMAN; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; WINE;

ANIMALIA; VITIS;

HUMANS; MALE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROSTATIC NEOPLASMS; TEA; WINE;

EID: 77957831195     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-160838     Document Type: Article

References (57)

1. Fitzpatrick, J. M., Schulman, C., Zlotta, A. R., and Schroder, F. H. (2009) Prostate cancer: a serious disease suitable for prevention. BJU Int. 103, 864-870
2. Surh, Y. J. (2003) Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3, 768-780
3. Aziz, M. H., Reagan-Shaw, S., Wu, J., Longley, B. J., and Ahmad, N. (2005) Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? FASEB J. 19, 1193-1195 (Pubitemid 40946462)
4. Fulda, S., and Debatin, K. M. (2006) Resveratrol modulation of signal transduction in apoptosis and cell survival: a mini-review. Cancer Detect. Prev. 30, 217-223
5. Aggarwal, B. B., and Shishodia, S. (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 71, 1397-1421
6. Johnson, J. J., Bailey, H. H., and Mukhtar, H. (2010) Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine 17, 3-13
7. Gupta, S., Hastak, K., Ahmad, N., Lewin, J. S., and Mukhtar, H. (2001) Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. U. S. A. 98, 10350-10355
8. Siddiqui, I. A., Zaman, N., Aziz, M. H., Reagan-Shaw, S. R., Sarfaraz, S., Adhami, V. M., Ahmad, N., Raisuddin, S., and Mukhtar, H. (2006) Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas. Carcinogenesis 27, 833-839
9. Harper, C. E., Patel, B. B., Wang, J., Arabshahi, A., Eltoum, I. A., and Lamartiniere, C. A. (2007) Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis 28, 1946-1953
10. Seeni, A., Takahashi, S., Takeshita, K., Tang, M., Sugiura, S., Sato, S. Y., and Shirai, T. (2008) Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model. Asian Pac. J. Cancer Prev. 9, 7-14
11. Spiegel, S., and Milstien, S. (2003) Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell. Biol. 4, 397-407
12. Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, S., and Spiegel, S. (1996) Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381, 800-803 (Pubitemid 26243122)
13. Alvarez, S. E., Milstien, S., and Spiegel, S. (2007) Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol. Metab. 18, 300-307
14. Van Brocklyn, J. R., Jackson, C. A., Pearl, D. K., Kotur, M. S., Snyder, P. J., and Prior, T. W. (2005) Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J. Neuropathol. Exp. Neurol. 64, 695-705
15. Li, W., Yu, C. P., Xia, J. T., Zhang, L., Weng, G. X., Zheng, H. Q., Kong, Q. L., Hu, L. J., Zeng, M. S., Zeng, Y. X., Li, M., Li, J., and Song, L. B. (2009) Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients. Clin. Cancer Res. 15, 1393-1399
16. Ruckhaberle, E., Rody, A., Engels, K., Gaetje, R., von Minckwitz, G., Schiffmann, S., Grosch, S., Geisslinger, G., Holtrich, U., Karn, T., and Kaufmann, M. (2008) Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res. Treat. 112, 41-52
17. Cuvillier, O., Ader, I., Bouquerel, P., Brizuela, L., Malavaud, B., Mazerolles, C., and Rischmann, P. (2010) Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting. Curr. Mol. Pharmacol. 3, 53-65
18. Pchejetski, D., Golzio, M., Bonhoure, E., Calvet, C., Doumerc, N., Garcia, V., Mazerolles, C., Rischmann, P., Teissie, J., Malavaud, B., and Cuvillier, O. (2005) Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res. 65, 11667-11675
19. Pchejetski, D., Doumerc, N., Golzio, M., Naymark, M., Teissie, J., Kohama, T., Waxman, J., Malavaud, B., and Cuvillier, O. (2008) Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models. Mol. Cancer Ther. 7, 1836-1845
20. Nava, V. E., Cuvillier, O., Edsall, L. C., Kimura, K., Milstien, S., Gelmann, E. P., and Spiegel, S. (2000) Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells. Cancer Res. 60, 4468-4474 (Pubitemid 32103627)
21. Dayon, A., Brizuela, L., Martin, C., Mazerolles, C., Pirot, N., Doumerc, N., Nogueira, L., Golzio, M., Teissié, J., Serre, G., Rischmann, P., Malavaud, B., and Cuvillier, O. (2009) Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth and survival. PLoS ONE 4, e8048
22. Pitson, S. M., Moretti, P. A., Zebol, J. R., Lynn, H. E., Xia, P., Vadas, M. A., and Wattenberg, B. W. (2003) Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J. 22, 5491-5500
23. Cuvillier, O., and Levade, T. (2001) Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria. Blood 98, 2828-2836
24. Bonhoure, E., Pchejetski, D., Aouali, N., Morjani, H., Levade, T., Kohama, T., and Cuvillier, O. (2006) Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1. Leukemia 20, 95-102
25. Martin, A., Gomez-Munoz, A., Waggoner, D. W., Stone, J. C., and Brindley, D. N. (1993) Decreased activities of phosphatidate phosphohydrolase and phospholipase D in ras and tyrosine kinase (fps) transformed fibroblasts. J. Biol. Chem. 268, 23924-23932
26. Bligh, E. G., and Dyer, W. J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917
27. Ader, I., Brizuela, L., Bouquerel, P., Malavaud, B., and Cuvillier, O. (2008) Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cells. Cancer Res. 68, 8635-8642
28. Ahmad, N., Feyes, D. K., Nieminen, A. L., Agarwal, R., and Mukhtar, H. (1997) Green tea constituent epigallocathecin-3- gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst. 89, 1881-1886 (Pubitemid 28009824)
29. Benitez, D. A., Pozo-Guisado, E., Alvarez-Barrientos, A., Fernandez-Salguero, P. M., and Castellon, E. A. (2007) Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines. J. Androl. 28, 282-293
30. Hastak, K., Gupta, S., Ahmad, N., Agarwal, M. K., Agarwal, M. L., and Mukhtar, H. (2003) Role of p53 and NF-kappaB in epigallocatechin- 3-gallate-induced apoptosis of LNCaP cells. Oncogene 22, 4851-4859 (Pubitemid 36981273)
31. Shankar, S., Siddiqui, I., and Srivastava, R. K. (2007) Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells. Mol. Cell. Biochem. 304, 273-285
32. Delon, C., Manifava, M., Wood, E., Thompson, D., Krugmann, S., Pyne, S., and Ktistakis, N. T. (2004) Sphingosine kinase 1 is an intracellular effector of phosphatidic acid. J. Biol. Chem. 279, 44763-44774
33. Jenkins, G. M., and Frohman, M. A. (2005) Phospholipase D: a lipid centric review. Cell. Mol. Life Sci. 62, 2305-2316
34. Brown, H. A., Henage, L. G., Preininger, A. M., Xiang, Y., and Exton, J. H. (2007) Biochemical analysis of phospholipase D. Methods Enzymol. 434, 49-87
35. Shimizu, M., Deguchi, A., Lim, J. T., Moriwaki, H., Kopelovich, L., and Weinstein, I. B. (2005) (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin. Cancer Res. 11, 2735-2746
36. Colin, D., Gimazane, A., Lizard, G., Izard, J. C., Solary, E., Latruffe, N., and Delmas, D. (2009) Effects of resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5fluoro-uracil sensitivity in human derived colon cancer cells. Int. J. Cancer 124, 2780-2788
37. Cuvillier, O., Rosenthal, D. S., Smulson, M. E., and Spiegel, S. (1998) Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and ceramide-mediated apoptosis in Jurkat T lymphocytes. J. Biol. Chem. 273, 2910-2916 (Pubitemid 28133941)
38. Bonhoure, E., Lauret, A., Barnes, D. J., Martin, C., Malavaud, B., Kohama, T., Melo, J. V., and Cuvillier, O. (2008) Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells. Leukemia 22, 971-979 (Pubitemid 351689879)
39. Olivera, A., Rosenthal, J., and Spiegel, S. (1996) Effect of acidic phospholipids on sphingosine kinase. J. Cell. Biochem. 60, 529-537 (Pubitemid 26112065)
40. Issuree, P. D., Pushparaj, P. N., Pervaiz, S., and Melendez, A. J. (2009) Resveratrol attenuates C5a-induced inflammatory responses in vitro and in vivo by inhibiting phospholipase D and sphingosine kinase activities. FASEB J. 23, 2412-2424
41. Johnson, K. R., Becker, K. P., Facchinetti, M. M., Hannun, Y. A., and Obeid, L. M. (2002) PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane: extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). J. Biol. Chem. 277, 35257-35262
42. Stewart, J. R., and O'Brian, C. A. (2004) Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKC alpha inhibition. Invest. New Drugs 22, 107-117
43. Vayalil, P. K., and Katiyar, S. K. (2004) Treatment of epigallocatechin- 3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells. Prostate 59, 33-42
44. Kang, D. W., Park, M. H., Lee, Y. J., Kim, H. S., Kwon, T. K., Park, W. S., and Min, D. S. (2008) Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NFkappaB-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells. J. Biol. Chem. 283, 4094-4104
45. Paruch, S., El-Benna, J., Djerdjouri, B., Marullo, S., and Perianin, A. (2006) A role of p44/42 mitogen-activated protein kinases in formyl-peptide receptor-mediated phospholipase D activity and oxidant production. FASEB J. 20, 142-144 (Pubitemid 43100494)
46. Lee, M. H., Choi, B. Y., Kundu, J. K., Shin, Y. K., Na, H. K., and Surh, Y. J. (2009) Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target. Cancer Res. 69, 7449-7458
47. Adhami, V. M., Siddiqui, I. A., Ahmad, N., Gupta, S., and Mukhtar, H. (2004) Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res. 64, 8715-8722
48. Gioeli, D., Mandell, J. W., Petroni, G. R., Frierson, H. F., Jr., and Weber, M. J. (1999) Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res. 59, 279-284 (Pubitemid 29048852)
49. Kohno, M., Momoi, M., Oo, M. L., Paik, J. H., Lee, Y. M., Venkataraman, K., Ai, Y., Ristimaki, A. P., Fyrst, H., Sano, H., Rosenberg, D., Saba, J. D., Proia, R. L., and Hla, T. (2006) Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol. Cell. Biol. 26, 7211-7223
50. Kawamori, T., Osta, W., Johnson, K. R., Pettus, B. J., Bielawski, J., Tanaka, T., Wargovich, M. J., Reddy, B. S., Hannun, Y. A., Obeid, L. M., and Zhou, D. (2006) Sphingosine kinase 1 is up-regulated in colon carcinogenesis. FASEB J. 20, 386-388
51. Kawamori, T., Kaneshiro, T., Okumura, M., Maalouf, S., Uflacker, A., Bielawski, J., Hannun, Y. A., and Obeid, L. M. (2009) Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J. 23, 405-414
52. Ju, J., Hong, J., Zhou, J. N., Pan, Z., Bose, M., Liao, J., Yang, G. Y., Liu, Y. Y., Hou, Z., Lin, Y., Ma, J., Shih, W. J., Carothers, A. M., and Yang, C. S. (2005) Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res. 65, 10623-10631
53. Xiao, H., Hao, X., Simi, B., Ju, J., Jiang, H., Reddy, B. S., and Yang, C. S. (2008) Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats. Carcinogenesis 29, 113-119 (Pubitemid 351201749)
54. Sauer, L., Nunes, J., Salunkhe, V., Skalska, L., Kohama, T., Cuvillier, O., Waxman, J., and Pchejetski, D. (2009) Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel. Int. J. Cancer 125, 2728-2736
55. Ader, I., Malavaud, B., and Cuvillier, O. (2009) When the sphingosine kinase-1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy. Cancer Res. 69, 3723-3726
56. Zhang, Q., Tang, X., Lu, Q., Zhang, Z., Rao, J., and Le, A. D. (2006) Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol. Cancer Ther. 5, 1227-1238
57. Zhang, Q., Tang, X., Lu, Q. Y., Zhang, Z. F., Brown, J., and Le, A. D. (2005) Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol. Cancer Ther. 4, 1465-1474